In last trading session, Tiziana Life Sciences Ltd (NASDAQ:TLSA) saw 0.38 million shares changing hands with its beta currently measuring 0.36. Company’s recent per share price level of $1.57 trading at $0.09 or 6.08% at ring of the bell on the day assigns it a market valuation of $173.74M. That closing price of TLSA’s stock is at a discount of -21.66% from its 52-week high price of $1.91 and is indicating a premium of 73.89% from its 52-week low price of $0.41. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.54 million shares which gives us an average trading volume of 1.02 million if we extend that period to 3-months.
For Tiziana Life Sciences Ltd (TLSA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) trade information
Upright in the green during last session for gaining 6.08%, in the last five days TLSA remained trading in the red while hitting it’s week-highest on Monday, 03/10/25 when the stock touched $1.57 price level, adding 14.68% to its value on the day. Tiziana Life Sciences Ltd’s shares saw a change of 125.51% in year-to-date performance and have moved -7.10% in past 5-day. Tiziana Life Sciences Ltd (NASDAQ:TLSA) showed a performance of 109.89% in past 30-days. Number of shares sold short was 0.57 million shares which calculate 0.8 days to cover the short interests.
Tiziana Life Sciences Ltd (TLSA) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -12.98% during past 5 years.
Tiziana Life Sciences Ltd (NASDAQ:TLSA)’s Major holders
Insiders are in possession of 35.56% of company’s total shares while institution are holding 0.89 percent of that, with stock having share float percentage of 1.38%. Investors also watch the number of corporate investors in a company very closely, which is 0.89% institutions for Tiziana Life Sciences Ltd that are currently holding shares of the company. ALPHAMARK ADVISORS, LLC is the top institutional holder at TLSA for having 4589.0 shares of worth $0.31 million. And as of 2024-06-30, it was holding 0.0045 of the company’s outstanding shares.
On the other hand, Fidelity Nasdaq Composite Index ETF and Fidelity NASDAQ Composite Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 167.84 shares of worth $0.26 million or 0.16% of the total outstanding shares. The later fund manager was in possession of 74.14 shares on Dec 31, 2024 , making its stake of worth around $0.12 million in the company or a holder of 0.07% of company’s stock.
